# BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study

Study · id `cardio:ct-nct04891380` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04891380](<https://clinicaltrials.gov/study/NCT04891380>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04891380

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 183 participants.

## Technical summary

Registry record NCT04891380. Non-randomized; no masking; primary purpose treatment. Start 2021-05-18 (actual); primary completion 2024-01-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 183 participants (enrolled count; ClinicalTrials.gov record NCT04891380, source copy `cardio:ctgov-nct04891380-2024-04-03`, retrieved 2026-10-26)
- Started: 2021-05-18 (actual) (ClinicalTrials.gov record NCT04891380, source copy `cardio:ctgov-nct04891380-2024-04-03`, retrieved 2026-10-26)
- Primary completion: 2024-01-03 (actual) (ClinicalTrials.gov record NCT04891380, source copy `cardio:ctgov-nct04891380-2024-04-03`, retrieved 2026-10-26)
- Completion: 2024-01-03 (actual) (ClinicalTrials.gov record NCT04891380, source copy `cardio:ctgov-nct04891380-2024-04-03`, retrieved 2026-10-26)
- Countries: Norway (ClinicalTrials.gov record NCT04891380, source copy `cardio:ctgov-nct04891380-2024-04-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04891380-2024-04-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study
- Condition: Cardiac Arrest, Out-Of-Hospital
- Condition: Hypotension and Shock
- Intervention (Device): LUCAS 2 Active Decompression 2
- Intervention (Other): Hypotension
- Intervention (Other): Intensive care transport
- Lead sponsor: Oslo University Hospital
- Lead sponsor class: OTHER
- Collaborator: Norwegian Telemedicine
- Collaborator class: UNKNOWN
- Collaborator: Kopera Norway
- Collaborator class: UNKNOWN
- Collaborator: Edwards Medical
- Collaborator class: UNKNOWN
- Collaborator: Stryker Medical
- Collaborator class: INDUSTRY
- Collaborator: University of Bilbao
- Collaborator class: UNKNOWN
- Collaborator: University of Stavanger
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Oslo University Hospital (`cardio:org-oslo-university-hospital`)

## Provenance

Content hash: f2d241449f78965b639b81a5813653d898dbc81841d40c5f0c77e45601f2be91
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
